![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Early On-treatment Responses to Telaprevir Are Lower, but Do Not Differ Significantly between HIV/HCV Co-infected and HCV Mono-infected Patients
|
|
|
Reported by Jules Levin
CROI 2012 March 5-8 Seattle, WA
Valerie Martel-Laferriere, Kian Bichoupan, Alexis Pappas, Emily Schonfeld, Alicia Stivala, Marie-Louise Vachon, Michel Ng, Mary Standen, Douglas Dieterich, Andrea Branch
Department of Medicine, Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, USA
![CROI1.gif](../images/032012/032012-5/CROI1.gif)
![CROI2.gif](../images/032012/032012-5/CROI2.gif)
![CROI3.gif](../images/032012/032012-5/CROI3.gif)
![CROI4.gif](../images/032012/032012-5/CROI4.gif)
![CROI5.gif](../images/032012/032012-5/CROI5.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|